Ikarian Capital, LLC Portfolio Holdings

Ikarian Capital, LLC

  • $328 Million
  • Q2 2025

Ikarian Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $328 Million distributed in 133 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Alnylam Pharmaceuticals, Inc. with a value of $18.5M, Insmed Inc with a value of $16.5M, Verona Pharma PLC with a value of $13.9M, Crinetics Pharmaceuticals, Inc. with a value of $12.5M, and Akero Therapeutics, Inc. with a value of $11.7M.

Examining the 13F form we can see an decrease of $386M in the current position value, from $714M to 328M.

Ikarian Capital, LLC is based out at Dallas, TX

Below you can find more details about Ikarian Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $328 Million
Healthcare: $327 Million
ETFs: $728,000

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$728,000 0.22% of portfolio
5,755
Q2 2025 New

Summary

  • Portfolio
  • No. of Stocks 133
  • Current Value $328 Million
  • Prior Value $714 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 24 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 28 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email